Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid Tumors

NCT00058253 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

80

Enrollment

NIH

Sponsor class

Conditions

Recurrent Prostate Cancer
Stage IV Prostate Cancer
Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: tanespimycin
DRUG: docetaxel

Sponsor

National Cancer Institute (NCI)